Thérapie par le récit : Questions médicales fréquentes
Nom anglais: Narrative Therapy
Descriptor UI:D062525
Tree Number:F04.754.570
Termes MeSH sélectionnés :
Attention Deficit Disorder with Hyperactivity
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par le récit : Questions médicales les plus fréquentes",
"headline": "Thérapie par le récit : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thérapie par le récit : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-21",
"dateModified": "2025-02-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thérapie par le récit"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Psychothérapie",
"url": "https://questionsmedicales.fr/mesh/D011613",
"about": {
"@type": "MedicalCondition",
"name": "Psychothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F04.754"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par le récit",
"alternateName": "Narrative Therapy",
"code": {
"@type": "MedicalCode",
"code": "D062525",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "A L Aguilar-Shea",
"url": "https://questionsmedicales.fr/author/A%20L%20Aguilar-Shea",
"affiliation": {
"@type": "Organization",
"name": "Medicina Familiar y Comunitaria, Centro de Salud Puerta de Madrid, Atención Primaria de Madrid, Madrid, España. Electronic address: antonio.aguilar@salud.madrid.org."
}
},
{
"@type": "Person",
"name": "Simon M Mueller",
"url": "https://questionsmedicales.fr/author/Simon%20M%20Mueller",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, University Hospital Basel, Switzerland. Electronic address: simon.mueller@usb.ch."
}
},
{
"@type": "Person",
"name": "Argyrios Chronopoulos",
"url": "https://questionsmedicales.fr/author/Argyrios%20Chronopoulos",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Hospital of Ludwigshafen, Akademisches Lehrkrankenhaus der Johannes-Gutenberg-Universität Mainz und der Medizinischen Fakultät Mannheim der Universität Heidelberg, Ludwigshafen am Rhein, Germany."
}
},
{
"@type": "Person",
"name": "Neele Babst",
"url": "https://questionsmedicales.fr/author/Neele%20Babst",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, University of Lübeck, Lübeck, Germany."
}
},
{
"@type": "Person",
"name": "Christian Schiemenz",
"url": "https://questionsmedicales.fr/author/Christian%20Schiemenz",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, University of Lübeck, Lübeck, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Wavelet-based approach for diagnosing attention deficit hyperactivity disorder (ADHD).",
"datePublished": "2022-12-19",
"url": "https://questionsmedicales.fr/article/36535997",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-26077-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Childhood School Performance in Adults Diagnosed with Attention-Deficit/Hyperactivity Disorder.",
"datePublished": "2022-12-09",
"url": "https://questionsmedicales.fr/article/36484286",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10870547221140601"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Attention-Deficit/Hyperactivity Disorder Diagnosis With Adolescent Quality of Life.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36227598",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2022.36364"
}
},
{
"@type": "ScholarlyArticle",
"name": "Shared genetics and causality underlying epilepsy and attention-deficit hyperactivity disorder.",
"datePublished": "2022-08-14",
"url": "https://questionsmedicales.fr/article/35994864",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.psychres.2022.114794"
}
},
{
"@type": "ScholarlyArticle",
"name": "Half a century of research on Attention-Deficit/Hyperactivity Disorder: A scientometric study.",
"datePublished": "2022-07-04",
"url": "https://questionsmedicales.fr/article/35798128",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neubiorev.2022.104769"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Disciplines et activités comportementales",
"item": "https://questionsmedicales.fr/mesh/D004191"
},
{
"@type": "ListItem",
"position": 3,
"name": "Psychothérapie",
"item": "https://questionsmedicales.fr/mesh/D011613"
},
{
"@type": "ListItem",
"position": 4,
"name": "Thérapie par le récit",
"item": "https://questionsmedicales.fr/mesh/D062525"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thérapie par le récit - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thérapie par le récit",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thérapie par le récit",
"description": "Comment diagnostiquer un besoin de thérapie par le récit ?\nQuels signes indiquent une bonne candidate pour cette thérapie ?\nQuels professionnels peuvent diagnostiquer ce besoin ?\nY a-t-il des tests spécifiques pour évaluer ce besoin ?\nComment évaluer l'efficacité de cette thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D062525?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thérapie par le récit",
"description": "Quels symptômes indiquent un besoin de thérapie narrative ?\nComment les récits personnels affectent-ils la santé mentale ?\nLes traumatismes influencent-ils les récits personnels ?\nQuels changements émotionnels peuvent survenir ?\nLes symptômes physiques peuvent-ils être liés aux récits ?",
"url": "https://questionsmedicales.fr/mesh/D062525?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thérapie par le récit",
"description": "Comment la thérapie narrative aide-t-elle à prévenir les troubles mentaux ?\nPeut-on utiliser cette thérapie en milieu scolaire ?\nQuels groupes peuvent bénéficier de la prévention par cette thérapie ?\nComment intégrer la thérapie narrative dans la vie quotidienne ?\nY a-t-il des programmes de prévention basés sur cette thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D062525?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thérapie par le récit",
"description": "Comment se déroule une séance de thérapie narrative ?\nQuels outils sont utilisés en thérapie narrative ?\nCombien de séances sont généralement nécessaires ?\nQuels résultats peut-on attendre de cette thérapie ?\nLa thérapie narrative est-elle adaptée à tous ?",
"url": "https://questionsmedicales.fr/mesh/D062525?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thérapie par le récit",
"description": "Quelles complications peuvent survenir lors de cette thérapie ?\nComment gérer les résistances en thérapie narrative ?\nLes récits peuvent-ils causer des traumatismes supplémentaires ?\nComment évaluer les risques avant de commencer ?\nLes complications sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D062525?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thérapie par le récit",
"description": "Quels facteurs augmentent le besoin de thérapie narrative ?\nLes antécédents familiaux influencent-ils ce besoin ?\nLe soutien social joue-t-il un rôle ?\nLes événements de vie stressants sont-ils des facteurs de risque ?\nLes croyances culturelles influencent-elles le recours à cette thérapie ?",
"url": "https://questionsmedicales.fr/mesh/D062525?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de thérapie par le récit ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un besoin peut être identifié par des difficultés émotionnelles persistantes et des récits de vie négatifs."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une bonne candidate pour cette thérapie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une personne ouverte à explorer ses expériences et désireuse de changer sa narration personnelle."
}
},
{
"@type": "Question",
"name": "Quels professionnels peuvent diagnostiquer ce besoin ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Psychologues, thérapeutes et conseillers formés à la thérapie narrative peuvent diagnostiquer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests spécifiques pour évaluer ce besoin ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de tests standardisés, mais des entretiens et des questionnaires peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité de cette thérapie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité peut être évaluée par des changements dans le bien-être émotionnel et la perception de soi."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de thérapie narrative ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des sentiments de dépression, d'anxiété ou de désespoir liés à des récits de vie négatifs."
}
},
{
"@type": "Question",
"name": "Comment les récits personnels affectent-ils la santé mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des récits négatifs peuvent renforcer des croyances limitantes et aggraver les symptômes psychologiques."
}
},
{
"@type": "Question",
"name": "Les traumatismes influencent-ils les récits personnels ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes peuvent altérer la perception de soi et la narration de l'histoire personnelle."
}
},
{
"@type": "Question",
"name": "Quels changements émotionnels peuvent survenir ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les individus peuvent ressentir une libération émotionnelle et une meilleure compréhension de soi."
}
},
{
"@type": "Question",
"name": "Les symptômes physiques peuvent-ils être liés aux récits ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des récits négatifs peuvent se manifester par des symptômes psychosomatiques comme des douleurs."
}
},
{
"@type": "Question",
"name": "Comment la thérapie narrative aide-t-elle à prévenir les troubles mentaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de restructurer les récits négatifs, réduisant ainsi le risque de troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser cette thérapie en milieu scolaire ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider les élèves à gérer leurs émotions et à développer des compétences sociales."
}
},
{
"@type": "Question",
"name": "Quels groupes peuvent bénéficier de la prévention par cette thérapie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les adolescents, les victimes de traumatismes et les personnes en transition de vie peuvent bénéficier."
}
},
{
"@type": "Question",
"name": "Comment intégrer la thérapie narrative dans la vie quotidienne ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer l'écriture de journaux et partager des histoires avec des proches peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des programmes de prévention basés sur cette thérapie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains programmes communautaires utilisent la thérapie narrative pour promouvoir le bien-être mental."
}
},
{
"@type": "Question",
"name": "Comment se déroule une séance de thérapie narrative ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le thérapeute guide le client à explorer et à reformuler ses récits personnels en toute sécurité."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés en thérapie narrative ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des métaphores, des journaux, et des récits écrits sont souvent utilisés pour faciliter l'exploration."
}
},
{
"@type": "Question",
"name": "Combien de séances sont généralement nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie, mais un engagement de plusieurs mois est souvent recommandé."
}
},
{
"@type": "Question",
"name": "Quels résultats peut-on attendre de cette thérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les résultats incluent une meilleure compréhension de soi, une réduction des symptômes et une résilience accrue."
}
},
{
"@type": "Question",
"name": "La thérapie narrative est-elle adaptée à tous ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut convenir à de nombreuses personnes, mais un diagnostic préalable est essentiel pour certains cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir lors de cette thérapie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des émotions intenses peuvent émerger, nécessitant un soutien supplémentaire du thérapeute."
}
},
{
"@type": "Question",
"name": "Comment gérer les résistances en thérapie narrative ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le thérapeute doit créer un espace sûr et utiliser des techniques adaptées pour surmonter les résistances."
}
},
{
"@type": "Question",
"name": "Les récits peuvent-ils causer des traumatismes supplémentaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, revisiter des récits traumatiques peut être difficile, d'où l'importance d'un encadrement professionnel."
}
},
{
"@type": "Question",
"name": "Comment évaluer les risques avant de commencer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation approfondie des antécédents et des besoins émotionnels est essentielle avant de commencer."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont pas fréquentes, mais chaque individu réagit différemment aux récits explorés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le besoin de thérapie narrative ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de traumatismes, des troubles émotionnels ou des transitions de vie difficiles peuvent augmenter le besoin."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils ce besoin ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles mentaux dans la famille peuvent accroître le risque de difficultés émotionnelles."
}
},
{
"@type": "Question",
"name": "Le soutien social joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faible soutien social peut augmenter le besoin de thérapie narrative en raison de l'isolement émotionnel."
}
},
{
"@type": "Question",
"name": "Les événements de vie stressants sont-ils des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des événements tels que le divorce ou la perte d'un emploi peuvent déclencher le besoin de cette thérapie."
}
},
{
"@type": "Question",
"name": "Les croyances culturelles influencent-elles le recours à cette thérapie ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines croyances culturelles peuvent affecter la perception de la thérapie narrative et son acceptation."
}
}
]
}
]
}
Attention deficit hyperactivity disorder (ADHD) is a common cognitive disorder affecting children. ADHD can interfere with educational, social, and emotional development, so early detection is essenti...
Children with ADHD often tend to underperform in school. This partial study aimed to find out if the school experience of adults with higher ADHD symptomatology differs from those with lower and no AD...
Based on the results of ASRS questionnaires, the respondents were divided into three groups (low, medium, and high) according to the manifested ADHD symptomatology. We explored their school experience...
Children with higher ADHD symptomatology were significantly more likely to be expelled, receive notes for bad behavior, disturbing or forgetting as well as receive reprimands from teachers....
Our results show that children with increased ADHD symptomatology experience more difficulties with school behavior, they are frequently reprimanded, and they do receive more negative feedback regardi...
Appropriate diagnosis of attention-deficit/hyperactivity disorder (ADHD) can improve some short-term outcomes in children and adolescents, but little is known about the association of a diagnosis with...
To compare QOL in adolescents with and without an ADHD diagnosis....
This cohort study followed an emulated target trial design using prospective, observational data from the Longitudinal Study of Australian Children, a representative, population-based prospective coho...
Incident parent-reported ADHD diagnosis at age 6 to 7, 8 to 9, 10 to 11, 12 to 13, or 14 to 15....
Quality of life at age 14 to 15 was measured with Child Health Utility 9D (CHU9D) and 8 other prespecified, self-reported measures mapped to the World Health Organization's QOL domains. Pooled regress...
Of 8643 eligible children, a total of 393 adolescents had an ADHD diagnosis (284 [72.2%] boys; mean [SD] age, 10.03 [0.30] years; mean [SD] H/I Strengths and Difficulties Questionnaire score, 5.05 [2....
In this cohort study, ADHD diagnosis was not associated with any self-reported improvements in adolescents' QOL compared with adolescents with similar levels of H/I behaviors but no ADHD diagnosis. AD...
The prevalence of attention deficit hyperactivity disorder (ADHD) in patients with epilepsy was much higher than prevalence in general population, and vice versa. The mechanisms underlying comorbid AD...
We performed a scientometric analysis of the scientific literature on ADHD to evaluate key themes and trends over the past decades, informing future lines of research. We conducted a systematic search...
To evaluate the acute efficacy, safety, and tolerability of lisdexamfetamine dimesylate (LDX) vs placebo (PBO) in preschool-aged children with attention-deficit/hyperactivity disorder (ADHD)....
This phase 3, double-blind, fixed-dose study randomly assigned children (aged 4-5 years) with ADHD to 6 weeks of LDX (5, 10, 20, 30 mg) or PBO. The prespecified primary (change from baseline at week 6...
The study comprised 199 participants randomly asigned 5:5:5:5:6 to receive 5, 10, 20, 30 mg LDX or PBO, respectively. Least squares (LS) mean (95% CI) treatment difference at week 6 between pooled LDX...
In children aged 4 to 5 years with ADHD, LDX was more efficacious than PBO in reducing symptoms. The observed ES for change in ADHD-RS-IV-PS-TS appears to be smaller in magnitude than has been reporte...
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-Deficit/Hyperactivity Disorder; http://www....
gov; NCT03260205....
The purpose of the current study was to examine the prevalence of attention deficit hyperactivity disorder (ADHD) in girls with central precocious puberty....
Girls with central precocious puberty were prospectively recruited from the pediatric clinic. Screening was done with ADHD Rating Scale (ADHD-RS) and Child Behavior Checklist (CBCL). Those who screene...
Among the 81 girls (mean age = 8.97 ± 0.91) who completed the study, 11 girls (13.58%) were diagnosed with ADHD: 5 of them were inattentive type and 6 of them were combined type....
The present exploratory study showed that the prevalence of ADHD in girls with central precocious was higher than the known worldwide prevalence of ADHD in children....
Improving neurocognitive functions through remote interventions has been a promising approach to developing new treatments for attention-deficit/hyperactivity disorder (AD/HD). Remote neurocognitive i...
Changes in protein glycosylation are associated with most biological processes, and the importance of glycomic analysis in the research of disorders is constantly increasing, including in the neurodev...
Few longitudinal studies have investigated whether white matter development reflects differential outcomes for children with and without attention-deficit/hyperactivity disorder (ADHD). To examine whe...
Participants (mean age at wave 1 = 10.39 years, scan interval = 18 months) underwent up to 3 magnetic resonance imaging assessments. White matter tracts were reconstructed using TractSeg, a semiautoma...
Compared with the non-ADHD group, the remitted and persistent ADHD groups showed accelerated fiber development in thalamic pathways, striatal pathways, and the superior longitudinal fasciculus. In the...
These results suggest that variations in white matter development are associated with different clinical trajectories in ADHD. The findings advance our understanding of the neurobiological mechanisms ...